---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-268239"
form_type: "8-K"
ticker: "CTS"
cik: "0000026058"
company_name: "CTS CORP"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:03:48.870797+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# CTS appoints Kimberly Banks MacKay to board, effective Nov 5, 2025

## Summary
- Board expands from 7 to 8 members; MacKay fills newly created vacancy.
- MacKay is SVP, General Counsel & Corporate Secretary of West Pharmaceutical Services.
- She will serve on Nominating, Governance & Sustainability and Technology & Transactions committees.
- Compensation is consistent with other non-employee directors, per prior proxy.

## SEC filing metadata
- accession: 0001193125-25-268239
- form_type: 8-K
- ticker: CTS
- cik: 0000026058
- company_name: CTS CORP
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/26058/000119312525268239/0001193125-25-268239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/26058/000119312525268239/cts-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-268239
- JSON: https://secwatch.observer/filing/0001193125-25-268239.json
- Plain text: https://secwatch.observer/filing/0001193125-25-268239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.